Illumina’s Billion Cell Atlas Grows: Formation Bio Joins Alliance
Illumina’s Billion Cell Atlas expands as AI‑native drug developer Formation Bio becomes the latest member of the alliance, a move that could reshape AI‑driven drug discovery by giving researchers unprecedented single‑cell perturbation data to accelerate therapeutic development. Illumina adds a third AI partner San Diego‑based Illumina (NASDAQ: ILMN) announced on July 16, 2026 that Formation Bio joins the…
